搜尋結果
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India S01AE03 - ciprofloxacin ; Belongs ...
Form. Cosyr (Reformulated) syr. Packing/Price. 120 mL x 1's;4 L x 1's. Cosyr (Reformulated) (Per 5 mL Dextromethorphan HBr 10 mg, chlorpheniramine maleate 1 mg): Cough in cold, flu, TB, bronchitis, bronchial asthma, pertussis,
Dosage/Direction for Use. SC Starting dose: 75 mg once every 2 wk. Alternative starting dose for patients who prefer less frequent dosing is 300 mg once every 4 wk (mthly). Max: 150 mg every 2 wk. Click to view Praluent detailed prescribing information.
IM Primary vaccination schedule of 2 doses (0.5 mL each): Initial dose followed by 2nd dose 2 mth later. If flexibility in the vaccination schedule is necessary, 2nd dose can be administered between 2 & 6 mth after the 1st dose. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after the initial dose.
Primal. Concise Prescribing Info. Contents. Theophylline. Indications/Uses. Continuous symptomatic treatment of persistent asthma & of other forms of COPD. Dosage/Direction for Use. Adult Initially 5-8 mg/kg/day. Usual effective dose: 7-12 mg/kg/day. Max: 800 mg/day. Childn 9-16 yr Initially 10-12 mg/kg/day. Usual effective dose: 10-16 mg/kg/day.
Smecta Symptomatic treatment of acute diarrhea in childn & infants in addition to oral rehydration, & in adults; chronic diarrhea; pain associated to oesophagus & gastroduodenal & colic disease. SmectaGo/Smecta Strawberry Treatment of acute diarrhoea in childn >2 yr in addition to oral rehydration, & in adults.
Dosage/Direction for Use. Adult & childn >12 yr Apply a thin layer of gel on small hyperpigmented surfaces. Childn Apply once daily for 10-15 days, only on the stain & continue the treatment w/ 2 daily applications, 1 in the morning & another at night. Click to view Licoforte detailed prescribing information.
